Capital Asset Pricing Model (CAPM)
Capital asset pricing model (CAPM) indicates what should be the expected or required rate of return on risky assets like Allergan PLC common stock.
Paying users area
Try for free
Allergan PLC pages available for free this week:
- Statement of Comprehensive Income
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Long-term (Investment) Activity Ratios
- Analysis of Reportable Segments
- Dividend Discount Model (DDM)
- Present Value of Free Cash Flow to Equity (FCFE)
- Net Profit Margin since 2005
- Return on Assets (ROA) since 2005
- Price to Book Value (P/BV) since 2005
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get 1-month access to Allergan PLC for $22.49, or
get full access to the entire website for at least 3 months from $62.19.
This is a one-time payment. There is no automatic renewal.
We accept:
Rates of Return
Allergan PLC, monthly rates of return
| Allergan PLC (AGN) | Standard & Poor’s 500 (S&P 500) | |||||
|---|---|---|---|---|---|---|
| t | Date | PriceAGN,t1 | DividendAGN,t1 | RAGN,t2 | PriceS&P 500,t | RS&P 500,t3 |
| Jan 31, 2015 | ||||||
| 1. | Feb 28, 2015 | |||||
| 2. | Mar 31, 2015 | |||||
| 3. | Apr 30, 2015 | |||||
| . | . | . | . | . | . | . |
| . | . | . | . | . | . | . |
| . | . | . | . | . | . | . |
| 58. | Nov 30, 2019 | |||||
| 59. | Dec 31, 2019 | |||||
| Average (R): | ||||||
| Standard deviation: | ||||||
| Allergan PLC (AGN) | Standard & Poor’s 500 (S&P 500) | |||||
|---|---|---|---|---|---|---|
| t | Date | PriceAGN,t1 | DividendAGN,t1 | RAGN,t2 | PriceS&P 500,t | RS&P 500,t3 |
| Jan 31, 2015 | ||||||
| 1. | Feb 28, 2015 | |||||
| 2. | Mar 31, 2015 | |||||
| 3. | Apr 30, 2015 | |||||
| 4. | May 31, 2015 | |||||
| 5. | Jun 30, 2015 | |||||
| 6. | Jul 31, 2015 | |||||
| 7. | Aug 31, 2015 | |||||
| 8. | Sep 30, 2015 | |||||
| 9. | Oct 31, 2015 | |||||
| 10. | Nov 30, 2015 | |||||
| 11. | Dec 31, 2015 | |||||
| 12. | Jan 31, 2016 | |||||
| 13. | Feb 29, 2016 | |||||
| 14. | Mar 31, 2016 | |||||
| 15. | Apr 30, 2016 | |||||
| 16. | May 31, 2016 | |||||
| 17. | Jun 30, 2016 | |||||
| 18. | Jul 31, 2016 | |||||
| 19. | Aug 31, 2016 | |||||
| 20. | Sep 30, 2016 | |||||
| 21. | Oct 31, 2016 | |||||
| 22. | Nov 30, 2016 | |||||
| 23. | Dec 31, 2016 | |||||
| 24. | Jan 31, 2017 | |||||
| 25. | Feb 28, 2017 | |||||
| 26. | Mar 31, 2017 | |||||
| 27. | Apr 30, 2017 | |||||
| 28. | May 31, 2017 | |||||
| 29. | Jun 30, 2017 | |||||
| 30. | Jul 31, 2017 | |||||
| 31. | Aug 31, 2017 | |||||
| 32. | Sep 30, 2017 | |||||
| 33. | Oct 31, 2017 | |||||
| 34. | Nov 30, 2017 | |||||
| 35. | Dec 31, 2017 | |||||
| 36. | Jan 31, 2018 | |||||
| 37. | Feb 28, 2018 | |||||
| 38. | Mar 31, 2018 | |||||
| 39. | Apr 30, 2018 | |||||
| 40. | May 31, 2018 | |||||
| 41. | Jun 30, 2018 | |||||
| 42. | Jul 31, 2018 | |||||
| 43. | Aug 31, 2018 | |||||
| 44. | Sep 30, 2018 | |||||
| 45. | Oct 31, 2018 | |||||
| 46. | Nov 30, 2018 | |||||
| 47. | Dec 31, 2018 | |||||
| 48. | Jan 31, 2019 | |||||
| 49. | Feb 28, 2019 | |||||
| 50. | Mar 31, 2019 | |||||
| 51. | Apr 30, 2019 | |||||
| 52. | May 31, 2019 | |||||
| 53. | Jun 30, 2019 | |||||
| 54. | Jul 31, 2019 | |||||
| 55. | Aug 31, 2019 | |||||
| 56. | Sep 30, 2019 | |||||
| 57. | Oct 31, 2019 | |||||
| 58. | Nov 30, 2019 | |||||
| 59. | Dec 31, 2019 | |||||
| Average (R): | ||||||
| Standard deviation: | ||||||
Show all
1 Data in US$ per share of common stock, adjusted for splits and stock dividends.
2 Rate of return on common stock of AGN during period t
3 Rate of return on S&P 500 (the market portfolio proxy) during period t
Variance and Covariance
Allergan PLC, calculation of variance and covariance of returns
| t | Date | RAGN,t | RS&P 500,t | (RAGN,t–RAGN)2 | (RS&P 500,t–RS&P 500)2 | (RAGN,t–RAGN)×(RS&P 500,t–RS&P 500) |
|---|---|---|---|---|---|---|
| 1. | Feb 28, 2015 | |||||
| 2. | Mar 31, 2015 | |||||
| 3. | Apr 30, 2015 | |||||
| . | . | . | . | . | . | . |
| . | . | . | . | . | . | . |
| . | . | . | . | . | . | . |
| 58. | Nov 30, 2019 | |||||
| 59. | Dec 31, 2019 | |||||
| Total (Σ): | ||||||
| t | Date | RAGN,t | RS&P 500,t | (RAGN,t–RAGN)2 | (RS&P 500,t–RS&P 500)2 | (RAGN,t–RAGN)×(RS&P 500,t–RS&P 500) |
|---|---|---|---|---|---|---|
| 1. | Feb 28, 2015 | |||||
| 2. | Mar 31, 2015 | |||||
| 3. | Apr 30, 2015 | |||||
| 4. | May 31, 2015 | |||||
| 5. | Jun 30, 2015 | |||||
| 6. | Jul 31, 2015 | |||||
| 7. | Aug 31, 2015 | |||||
| 8. | Sep 30, 2015 | |||||
| 9. | Oct 31, 2015 | |||||
| 10. | Nov 30, 2015 | |||||
| 11. | Dec 31, 2015 | |||||
| 12. | Jan 31, 2016 | |||||
| 13. | Feb 29, 2016 | |||||
| 14. | Mar 31, 2016 | |||||
| 15. | Apr 30, 2016 | |||||
| 16. | May 31, 2016 | |||||
| 17. | Jun 30, 2016 | |||||
| 18. | Jul 31, 2016 | |||||
| 19. | Aug 31, 2016 | |||||
| 20. | Sep 30, 2016 | |||||
| 21. | Oct 31, 2016 | |||||
| 22. | Nov 30, 2016 | |||||
| 23. | Dec 31, 2016 | |||||
| 24. | Jan 31, 2017 | |||||
| 25. | Feb 28, 2017 | |||||
| 26. | Mar 31, 2017 | |||||
| 27. | Apr 30, 2017 | |||||
| 28. | May 31, 2017 | |||||
| 29. | Jun 30, 2017 | |||||
| 30. | Jul 31, 2017 | |||||
| 31. | Aug 31, 2017 | |||||
| 32. | Sep 30, 2017 | |||||
| 33. | Oct 31, 2017 | |||||
| 34. | Nov 30, 2017 | |||||
| 35. | Dec 31, 2017 | |||||
| 36. | Jan 31, 2018 | |||||
| 37. | Feb 28, 2018 | |||||
| 38. | Mar 31, 2018 | |||||
| 39. | Apr 30, 2018 | |||||
| 40. | May 31, 2018 | |||||
| 41. | Jun 30, 2018 | |||||
| 42. | Jul 31, 2018 | |||||
| 43. | Aug 31, 2018 | |||||
| 44. | Sep 30, 2018 | |||||
| 45. | Oct 31, 2018 | |||||
| 46. | Nov 30, 2018 | |||||
| 47. | Dec 31, 2018 | |||||
| 48. | Jan 31, 2019 | |||||
| 49. | Feb 28, 2019 | |||||
| 50. | Mar 31, 2019 | |||||
| 51. | Apr 30, 2019 | |||||
| 52. | May 31, 2019 | |||||
| 53. | Jun 30, 2019 | |||||
| 54. | Jul 31, 2019 | |||||
| 55. | Aug 31, 2019 | |||||
| 56. | Sep 30, 2019 | |||||
| 57. | Oct 31, 2019 | |||||
| 58. | Nov 30, 2019 | |||||
| 59. | Dec 31, 2019 | |||||
| Total (Σ): | ||||||
Show all
VarianceAGN = Σ(RAGN,t–RAGN)2 ÷ (59 – 1)
= ÷ (59 – 1)
=
VarianceS&P 500 = Σ(RS&P 500,t–RS&P 500)2 ÷ (59 – 1)
= ÷ (59 – 1)
=
CovarianceAGN, S&P 500 = Σ(RAGN,t–RAGN)×(RS&P 500,t–RS&P 500) ÷ (59 – 1)
= ÷ (59 – 1)
=
Systematic Risk (β) Estimation
| VarianceAGN | |
| VarianceS&P 500 | |
| CovarianceAGN, S&P 500 | |
| Correlation coefficientAGN, S&P 5001 | |
| βAGN2 | |
| αAGN3 |
Calculations
1 Correlation coefficientAGN, S&P 500
= CovarianceAGN, S&P 500 ÷ (Standard deviationAGN × Standard deviationS&P 500)
= ÷ ( × )
=
2 βAGN
= CovarianceAGN, S&P 500 ÷ VarianceS&P 500
= ÷
=
3 αAGN
= AverageAGN – βAGN × AverageS&P 500
= – ×
=
Expected Rate of Return
| Assumptions | ||
| Rate of return on LT Treasury Composite1 | RF | |
| Expected rate of return on market portfolio2 | E(RM) | |
| Systematic risk (β) of Allergan PLC common stock | βAGN | |
| Expected rate of return on Allergan PLC common stock3 | E(RAGN) | |
1 Unweighted average of bid yields on all outstanding fixed-coupon U.S. Treasury bonds neither due or callable in less than 10 years (risk-free rate of return proxy).
3 E(RAGN) = RF + βAGN [E(RM) – RF]
= + [ – ]
=